Hemn Abdulrahman Abdullah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hemn Abdulrahman Abdullah has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Darya Nadir Saeed
Department of Cardiovascular and Thoracic Surgery, Ministry of Health, Erbil, Iraq
2 shared publications- Abdullah Haider Flayeh
Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Iraq
1 shared publication Abdullah Hayder Flaih
Department of Biology, College of Sciences, Salahaddin University-Erbil, Erbil, Iraq
1 shared publication- Ahmed Abdulrazzaq Bapir
Department of Medical Laboratory Technology, Erbil Health and Medical Technical College, Erbil Polytechnic University, Erbil 44001, Kurdistan Region, Iraq
1 shared publication - Akhter Ahmed Ahmed
Department of Biology, College of Science, Salahaddin University-Erbil, Erbil 44001, Kurdistan Region, Iraq
1 shared publication - Blnd Azad Ismail
Department of Biology, College of Science, Salahaddin University-Erbil, Erbil 44001, Kurdistan Region, Iraq
1 shared publication
Latest Publications
- Open Access
Harnessing Living Therapies: The Role of CAR-T Cells, Oncolytic Viruses, and Bacteria in Cancer Treatment
Living therapies, including chimeric antigen receptor T (CAR-T) cells, oncolytic viruses (OVs), and bacteria-based platforms, are emerging as promising approaches in cancer treatment because they can directly target tumors and modulate anti-tumor immunity. This narrative review summarizes current knowledge on these therapies, focusing on their mechanisms of action, therapeutic applications, major limitations, and recent advances in genetic engineering, synthetic biology, and delivery systems. CAR-T cell therapy has shown substantial clinical success in hematological malignancies through the genetic redirection of T cells against tumor-associated antigens, although its efficacy in solid tumors remains limited by antigen heterogeneity and the immunosuppressive tumor microenvironment (TME). OVs selectively infect and lyse malignant cells while also stimulating local and systemic immune responses, and engineered OVs may further enhance therapeutic activity by reshaping the TME. Bacteria-based therapies exploit the natural tumor-targeting ability of selected strains, particularly in hypoxic regions, to deliver therapeutic agents and activate immune responses. Despite encouraging progress, safety concerns, immune-related barriers, and tumor complexity remain major challenges. Overall, integrating living therapies with modern biotechnological advances and existing treatment modalities may support more personalized and synergistic strategies for cancer management.
Open AccessHarnessing Living Therapies: The Role of CAR-T Cells, Oncolytic Viruses, and Bacteria in Cancer Treatment
Living therapies, including chimeric antigen receptor T (CAR-T) cells, oncolytic viruses (OVs), and bacteria-based platforms, are emerging as promising approaches in cancer treatment because they can directly target tumors and modulate anti-tumor immunity. This narrative review summarizes current knowledge on these therapies, focusing on their mechanisms of action, therapeutic applications, major limitations, and recent advances in genetic engineering, synthetic biology, and delivery systems. CAR-T cell therapy has shown substantial clinical success in hematological malignancies through the genetic redirection of T cells against tumor-associated antigens, although its efficacy in solid tumors remains limited by antigen heterogeneity and the immunosuppressive tumor microenvironment (TME). OVs selectively infect and lyse malignant cells while also stimulating local and systemic immune responses, and engineered OVs may further enhance therapeutic activity by reshaping the TME. Bacteria-based therapies exploit the natural tumor-targeting ability of selected strains, particularly in hypoxic regions, to deliver therapeutic agents and activate immune responses. Despite encouraging progress, safety concerns, immune-related barriers, and tumor complexity remain major challenges. Overall, integrating living therapies with modern biotechnological advances and existing treatment modalities may support more personalized and synergistic strategies for cancer management.
- Open Access
- 24 December 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Impact of surgical urgency on outcomes after minimally invasive coronary artery bypass surgery: a retrospective cohort study
Background: Surgical urgency in minimally invasive coronary artery bypass grafting (MICS-CABG) is associated with increased perioperative risk. This study evaluates the impact of surgical urgency on early postoperative outcomes in patients undergoing isolated MICS-CABG. Methods: A retrospective cohort study was conducted at Shar Hospital, Erbil, Iraq, including 311 patients who underwent isolated MICS-CABG between September 2021 and December 2024. Patients were classified as elective group ( n = 285) and urgent group ( n = 26) according to Society of Thoracic Surgeons criteria. Baseline demographics, intraoperative variables, and early postoperative outcomes were compared using appropriate statistical tests with a significance level of p < 0.05. Results: Baseline characteristics, including, gender, and body mass index, showed no significant differences between elective and urgent groups. However, the urgent group had significantly lower preoperative left ventricular ejection fraction (49.2% ± 12.0 vs. 53.8% ± 10.0, p = 0.032) and higher preoperative serum creatinine levels (1.59 ± 1.58 vs. 1.19 ± 1.94 mg/dL, p = 0.008). Intraoperatively, urgent patients required more vasopressor support (adrenaline: 26.9% vs. 10.2%, p = 0.020; noradrenaline: 73.1% vs. 40.7%, p = 0.001). Postoperatively, urgent cases had higher serum creatinine (1.86 ± 1.79 vs. 1.14 ± 0.58 mg/dL, p = 0.037) and more frequent incidence of acute respiratory failure in urgent group (39.1% vs. 17.5%, p = 0.023). Conclusions: Urgent MICS-CABG was associated with increased vasopressor use, renal dysfunction, and respiratory complications. Trial registration: Not applicable.
- 24 December 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Open AccessImpact of surgical urgency on outcomes after minimally invasive coronary artery bypass surgery: a retrospective cohort study
Background: Surgical urgency in minimally invasive coronary artery bypass grafting (MICS-CABG) is associated with increased perioperative risk. This study evaluates the impact of surgical urgency on early postoperative outcomes in patients undergoing isolated MICS-CABG. Methods: A retrospective cohort study was conducted at Shar Hospital, Erbil, Iraq, including 311 patients who underwent isolated MICS-CABG between September 2021 and December 2024. Patients were classified as elective group ( n = 285) and urgent group ( n = 26) according to Society of Thoracic Surgeons criteria. Baseline demographics, intraoperative variables, and early postoperative outcomes were compared using appropriate statistical tests with a significance level of p < 0.05. Results: Baseline characteristics, including, gender, and body mass index, showed no significant differences between elective and urgent groups. However, the urgent group had significantly lower preoperative left ventricular ejection fraction (49.2% ± 12.0 vs. 53.8% ± 10.0, p = 0.032) and higher preoperative serum creatinine levels (1.59 ± 1.58 vs. 1.19 ± 1.94 mg/dL, p = 0.008). Intraoperatively, urgent patients required more vasopressor support (adrenaline: 26.9% vs. 10.2%, p = 0.020; noradrenaline: 73.1% vs. 40.7%, p = 0.001). Postoperatively, urgent cases had higher serum creatinine (1.86 ± 1.79 vs. 1.14 ± 0.58 mg/dL, p = 0.037) and more frequent incidence of acute respiratory failure in urgent group (39.1% vs. 17.5%, p = 0.023). Conclusions: Urgent MICS-CABG was associated with increased vasopressor use, renal dysfunction, and respiratory complications. Trial registration: Not applicable.
- Open Access
- 30 July 2025
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (1) , 62-64
Minimally Invasive Mitral Valve Repair and Coronary Artery Bypass Graft by a Periareolar Approach
- 30 July 2025
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (1) , 62-64
Open AccessMinimally Invasive Mitral Valve Repair and Coronary Artery Bypass Graft by a Periareolar Approach